Total Payments
$154,170
2024 Payments
$68,945
Companies
14
Transactions
167
Medicare Patients
6,649
Medicare Billing
$707,187
Payment Breakdown by Category
Other$135,721 (88.0%)
Travel$12,988 (8.4%)
Food & Beverage$5,280 (3.4%)
Education$180.98 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $135,721 | 56 | 88.0% |
| Travel and Lodging | $12,988 | 28 | 8.4% |
| Food and Beverage | $5,280 | 81 | 3.4% |
| Education | $180.98 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $70,352 | 45 | $0 (2024) |
| Novo Nordisk Inc | $44,276 | 27 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $21,000 | 46 | $0 (2024) |
| Lilly USA, LLC | $13,065 | 10 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $2,308 | 6 | $0 (2023) |
| Janssen Research & Development, LLC | $1,457 | 11 | $0 (2017) |
| Medtronic, Inc. | $640.36 | 8 | $0 (2024) |
| Abbott Laboratories | $359.97 | 5 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $207.91 | 2 | $0 (2019) |
| Boston Scientific Corporation | $169.78 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $68,945 | 60 | Novo Nordisk Inc ($44,276) |
| 2023 | $38,359 | 28 | Boehringer Ingelheim Pharmaceuticals, Inc. ($34,358) |
| 2022 | $21,817 | 19 | Boehringer Ingelheim Pharmaceuticals, Inc. ($17,331) |
| 2021 | $90.02 | 1 | BOSTON SCIENTIFIC CORPORATION ($90.02) |
| 2019 | $217.85 | 2 | AtriCure, Inc. ($114.36) |
| 2018 | $12,630 | 23 | Actelion Pharmaceuticals US, Inc. ($12,516) |
| 2017 | $12,112 | 34 | Actelion Pharmaceuticals US, Inc. ($8,113) |
All Payment Transactions
167 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.53 | General |
| Category: Obesity | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | Medtronic, Inc. | HARMONY (Device) | Food and Beverage | In-kind items and services | $97.04 | General |
| Category: Heart Valves | ||||||
| 12/09/2024 | Medtronic, Inc. | HARMONY (Device) | Travel and Lodging | In-kind items and services | $320.02 | General |
| Category: Heart Valves | ||||||
| 12/09/2024 | Medtronic, Inc. | HARMONY (Device) | Travel and Lodging | In-kind items and services | $4.68 | General |
| Category: Heart Valves | ||||||
| 12/02/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,550.00 | General |
| 11/13/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,550.00 | General |
| 11/12/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,550.00 | General |
| 11/12/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $6.87 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,550.00 | General |
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $897.75 | General |
| Category: DIABETES | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $95.80 | General |
| Category: DIABETES | ||||||
| 11/05/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,550.00 | General |
| 10/31/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,550.00 | General |
| 10/29/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,393.75 | General |
| 10/29/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $612.31 | General |
| 10/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/28/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,550.00 | General |
| 10/28/2024 | Medtronic, Inc. | HARMONY (Device) | Food and Beverage | In-kind items and services | $41.20 | General |
| Category: Heart Valves | ||||||
| 10/25/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $79.76 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/23/2024 | Medtronic, Inc. | HARMONY (Device) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Heart Valves | ||||||
| 10/22/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,550.00 | General |
| 09/25/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $100.31 | General |
| Category: Cardiology | ||||||
| 09/24/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,037.50 | General |
| 09/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $117.17 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,828 | 2,629 | $753,674 | $170,785 |
| 2022 | 23 | 1,978 | 3,090 | $856,194 | $199,579 |
| 2021 | 20 | 1,589 | 2,440 | $754,010 | $184,331 |
| 2020 | 16 | 1,254 | 1,892 | $438,533 | $152,492 |
Total Patients
6,649
Total Services
10,051
Medicare Billing
$707,187
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 438 | 710 | $259,860 | $59,686 | 23.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 167 | 171 | $95,760 | $22,717 | 23.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 58 | 58 | $72,094 | $18,668 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 113 | 113 | $53,788 | $11,996 | 22.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 55 | 102 | $34,884 | $8,914 | 25.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 72 | 150 | $34,050 | $8,784 | 25.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 44 | 173 | $31,832 | $7,707 | 24.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 439 | 630 | $25,830 | $6,037 | 23.4% |
| 93724 | Electronic analysis of pacemaker to correct rapid heart rate | Office | 2023 | 19 | 26 | $21,112 | $5,186 | 24.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 45 | 46 | $17,204 | $4,154 | 24.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 90 | 91 | $18,291 | $4,117 | 22.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 30 | $14,940 | $4,019 | 26.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 81 | 83 | $16,268 | $3,694 | 22.7% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 58 | 115 | $46,805 | $2,244 | 4.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 25 | 28 | $8,540 | $2,213 | 25.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 30 | 33 | $1,188 | $316.47 | 26.6% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 23 | 26 | $520.00 | $142.74 | 27.5% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 13 | 13 | $429.00 | $115.44 | 26.9% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 28 | 31 | $279.00 | $73.47 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 429 | 695 | $263,725 | $59,302 | 22.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 132 | 355 | $103,696 | $27,492 | 26.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 58 | 58 | $77,319 | $20,337 | 26.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 111 | 118 | $69,846 | $16,306 | 23.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 64 | 64 | $36,334 | $9,460 | 26.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 80 | 163 | $33,305 | $8,923 | 26.8% |
About Dr. Tabitha Moe, M.D
Dr. Tabitha Moe, M.D is a Cardiovascular Disease healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1508067588.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tabitha Moe, M.D has received a total of $154,170 in payments from pharmaceutical and medical device companies, with $68,945 received in 2024. These payments were reported across 167 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($135,721).
As a Medicare-enrolled provider, Moe has provided services to 6,649 Medicare beneficiaries, totaling 10,051 services with total Medicare billing of $707,187. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Phoenix, AZ
- Active Since 05/29/2007
- Last Updated 04/26/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1508067588
Products in Payments
- JARDIANCE (Drug) $83,418
- Ozempic (Drug) $14,089
- UPTRAVI (Drug) $6,970
- LifeVest (Device) $2,308
- XARELTO (Drug) $1,665
- HARMONY (Device) $634.24
- OPSUMIT (Drug) $264.31
- CARDIOMEMS (Device) $245.79
- OPSUMIT MACITENTAN (Drug) $220.87
- Contegra (Device) $119.81
- EPI-SENSE GUIDED COAGULATION SYS (Device) $114.36
- SYNERGY (Device) $90.02
- CardioMEMS HF System (Device) $89.18
- WATCHMAN FLX (Device) $79.76
- CARDIVA VASCADE 5F VCS (Device) $73.12
- Perclose ProGlide suture mediated closure system (Device) $25.00
- Wegovy (Drug) $18.06
- Rybelsus (Drug) $7.26
- MICRA (Device) $6.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Phoenix
Ashish Gupta, M.d, M.D
Cardiovascular Disease — Payments: $1.2M
Cardiovascular Disease $1.2M
Dr. Timothy Byrne, Do, DO
Cardiovascular Disease — Payments: $838,695
Cardiovascular Disease $838,695
Dr. J. Weiss, M.d, M.D
Cardiovascular Disease — Payments: $288,755
Cardiovascular Disease $288,755
Dr. Akil Loli, Md, MD
Cardiovascular Disease — Payments: $139,062
Cardiovascular Disease $139,062
Mark Seifert, Md, MD
Cardiovascular Disease — Payments: $132,833
Cardiovascular Disease $132,833
Dr. Radha Gopalan, Md, MD
Cardiovascular Disease — Payments: $115,908
Cardiovascular Disease $115,908